Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Pathogenesis of hepatic encephalopathy.

E A Jones1

  • 1Department of Gastrointestinal and Liver Diseases, Academic Medical Center, Amsterdam, The Netherlands. E.A.Jones@AMC.UVA.NL

Clinics in Liver Disease
|March 10, 2001
PubMed
Summary

Hepatic encephalopathy (HE) is a reversible brain dysfunction in liver failure. Therapies targeting ammonia reduction may help normalize inhibitory neurotransmission in the central nervous system (CNS).

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Increases in the enzyme activity of mouse mammary explants induced by prolactin.

The Journal of endocrinology·2025
Same author

The role of receptor MAS in microglia-driven retinal vascular development.

Angiogenesis·2019
Same author

Genotype-phenotype correlation in a large English cohort of patients with autosomal recessive ichthyosis.

The British journal of dermatology·2019
Same author

Mesoderm induction in the future tail region of Xenopus.

Roux's archives of developmental biology : the official organ of the EDBO·2017
Same author

Mesenchymal stem cells, autoimmunity and rheumatoid arthritis.

QJM : monthly journal of the Association of Physicians·2014
Same author

To admit or not to admit on the morning of surgery patients' perspectives on day of surgery admission.

Journal of perioperative practice·2013

Area of Science:

  • Neuroscience
  • Hepatology
  • Biochemistry

Background:

  • Hepatic encephalopathy (HE) is a reversible metabolic encephalopathy linked to liver failure.
  • It involves increased portal-systemic shunting of gut-derived nitrogenous compounds.
  • HE manifests as global central nervous system (CNS) depression.

Purpose of the Study:

  • To explore the neurochemical basis of HE, focusing on neurotransmitter systems.
  • To understand the role of ammonia and GABAergic tone in HE pathogenesis.
  • To identify therapeutic targets for HE.

Main Methods:

  • Review of existing literature on HE pathophysiology.
  • Analysis of the interplay between ammonia, GABA, and benzodiazepine receptor agonists.
  • Examination of neurosteroid modulation of GABAergic tone.

Main Results:

  • HE involves an imbalance favoring inhibitory neurotransmission (GABA) over excitatory neurotransmission (glutamate).
  • Elevated ammonia may directly and indirectly enhance GABAergic tone.
  • Increased brain benzodiazepine receptor agonists and neurosteroids contribute to enhanced GABAergic activity.

Conclusions:

  • Therapeutic strategies for HE should aim to reduce ammonia levels.
  • Modulating GABAergic tone towards physiological levels is a rational therapeutic approach for HE.
  • Targeting ammonia and GABAergic pathways offers a promising avenue for HE treatment.

Related Experiment Videos